Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Safety and efficacy of a standardized intracameral combination of mydriatics and anesthetic for cataract surgery in type-2 diabetic patients

Fig. 1

Efficacy of mydriasis in diabetic and non-diabetic patients (mITT set) who received ICMA for intracameral injection at the beginning of cataract surgery (Mydrane) or a standard topical regimen (Topical) for cataract surgery. a Successful capsulorhexis without any additional mydriatic treatment (Primary efficacy variable). b Successful capsulorhexis without any additional mydriatic treatment and a pupil size of at least 6 mm (Supplementary efficacy variable). ICMA = intracameral combination of two mydriatics and one anaesthetic; p < 0.05 is statistically significant

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us